Quintiles to help Malaysia compete on clinical research work; Ventria forges supply pact with Merck KGaA;

> Quintiles has struck a deal to help the Malaysian Biotechnology Corp. to build a clinical research infrastructure in the country. The global biopharma services group will help create the kind of lab support and clinical expertise needed to make Malaysia more competitive for clinical research work. Story

> Ventria Bioscience has scored a supply deal with Merck KGaA. The Fort Collins, CO-based Ventria says it struck a contract to supply a recombinant protein for the life sciences arm of Merck KGaA. And EMD Millipore will market the product globally. "This collaboration with EMD Millipore, an industry leader in biomanufacturing, aligns Ventria's recombinant protein manufacturing technology with EMD Millipore's technical applications expertise and customer relationships in research, development and bioproduction," said Randy Semadeni, Ventria's VP for business development. Release

> The U.K. CRO QED Clinical Services has set up a subsidiary in India to broaden the scope of services it is offering clients. Story

> The American College of Radiology has named Dr. Donald P. Rosen chief executive officer of ACR Image Metrix, its CRO subsidiary. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.